RxDoctor Payments Data

Elizabeth Helsper, MD

Hand Surgery · Sioux Falls, SDNPI 1871942292

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,088 of the $7,275 with a category attached, or 69.9%. 16 manufacturers reported payments, led by Stryker at 58.9% of the total. Reporting peaked in 2023 at $2,890 and has fallen 67.7% since, to $934 in 2025.

$7,275in general payments, 2019–2025

Across 77 payments — averaging $94.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$4K
  • Linvatec Corporation$729
  • Integra Lifesciences Corporation$586
  • Johnson & Johnson$308
  • Medical Device Business Services, Inc.$269
  • Axogen$250
  • plus $851 from 10 others

What the payments were for

  • Travel & lodging$1,75024%
  • Food & beverage$5,08870%
  • Education$4376%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few hand surgery providers in South Dakotato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$78,016
Medicare patients
163
Services billed
423

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam70$215
Tamsulosin Hcl11$79
Cephalexin11$47
Montelukast Sodium12$14
Atorvastatin Calcium12$5

Paid to pharmacies, not to this prescriber.

Other hand surgery in Sioux Falls

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →